Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
CAD 0,0050
0,00%
(0,00) 1D
28 Okt., 13:31:29 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
285,35 k
Avg. vol.
773,00
Volume
0,00
52-wk high
CAD 0,01
52-wk low
CAD 0,00
EPS
-CAD 0,00
Beta
14,27
Shares outstanding
57,07 m
Mkt. cap
285,35 k
Avg. vol.
773,00
Volume
0,00
52-wk high
CAD 0,01
52-wk low
CAD 0,00
EPS
-CAD 0,00
Beta
14,27
Shares outstanding
57,07 m
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
HeadquartersVancouver, Brits-Columbië, Kanada
SectorHealth Care
Industry-
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,77 k
2,06 k
2,95 k
1,58 k
Operating expense
34,77 k
2,06 k
2,95 k
1,58 k
Total operating expenses
34,77 k
2,06 k
2,95 k
1,58 k
Operating income
-34,77 k
-2,06 k
-2,95 k
-1,58 k
Other non operating income
-2,27 k
-1,16 k
-10,54 k
-1,91 k
EBT including unusual items
-39,64 k
-5,83 k
-16,55 k
-6,82 k
EBT excluding unusual items
-39,64 k
-5,83 k
-16,55 k
-6,82 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39,64 k
-5,83 k
-16,55 k
-6,82 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,61 k
-2,61 k
-3,06 k
-3,33 k
Net interest expenses
-2,61 k
-2,61 k
-3,06 k
-3,33 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,38 k
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme